Antibacterial Agents TRIZ Cases

A bioresorbable polymer mesh elutes rifampin and minocycline to prevent biofilm formation at the transdermal access port site.

Lactobacillus paracasei GLU70 strain degrades gluten proteins while providing antibacterial activity in fermented food compositions.

Succinyl-farnesyl-cysteine compounds overcome antibiotic resistance by simultaneously inhibiting inflammation and preventing bacterial colonization.

Cysteamine dispersants disrupt biofilms to restore antibiotic effectiveness against resistant bacterial infections.

Compounds of formula I modulate metalloenzyme activity through sigma and coordinate-covalent bonds with active site metal ions.

Specific NEP inhibitor structures minimize central nervous system Aβ peptide concentration increases while treating hypertension.

A multi-functional adsorbing material couples amino-functionalized carriers with broad-spectrum ligands to capture diverse pathogenic factors from blood.

Myoviridae bacteriophage Pas-MUP-1 targets Pasteurella multocida via local quality and intermediary principles, avoiding antibiotic resistance.

Modified therapeutic agents bypass direct vascular entry to achieve controlled release and steady state concentration.

Purified Salvia tanshinone extract with defined compound ratios delivers strong antibacterial activity against drug-resistant bacteria.

Modifying monocyclic beta-lactam structures overcomes bacterial resistance mechanisms in Gram-negative infections, restoring treatment efficacy.

Isolated polypeptides mimic the TcdB binding domain to compete for Frizzled receptors, blocking toxin entry and reducing Clostridium difficile recurrence.

Combines sodium fluoride with stabilized chlorine dioxide in a buffered pH range to disrupt biofilm and promote tooth remineralization.

A bedaquiline nanoparticle suspension with a poloxamer surface modifier maintains therapeutic plasma levels through sustained release.

Solid magnetic nanoparticles immobilize enzymes activating upon hydration to produce antimicrobial agents, reducing contamination without antibiotic resistance.

Stapled peptides resist protease degradation while blocking bacterial adhesion.

Topical probiotic compositions inhibit pathogenic microbes on human skin, addressing resistance and toxicity from conventional antifungals.

T-cell epitope delivering polypeptides transport CD8+ T-cell antigens to the MHC class I presentation pathway within target cells.

A pharmaceutical composition uses lauroyl-carnitine, citric acid, and sodium citrate to enhance oral bioavailability.

Modular inhibitor scaffolds resolve the selectivity versus complexity trade-off by targeting BRD2, BRD3, and BRD4 for treating neurodegenerative diseases.

Novel ciprofloxacin derivatives incorporating a pyridoxine fragment exhibit high antibacterial activity against gram-positive and gram-negative bacteria.

Phosphate group modifications stabilize Loop 3 conformations, resolving insufficient antibacterial potency in previous linked purine pterin inhibitors.

Hyperimmune globulin delivers high opsonic antibody titers to overcome insufficient protection in standard intravenous immunoglobulin preparations.

A stable quaternary ammonium complex merges carvacrol and lidocaine into a single antimicrobial agent.

Segmented UspA1 and UspA2 polypeptides bind fibronectin, laminin, and C3 to prevent Moraxella catarrhalis infections.

Engineering a single human VH segment in mice accelerates therapeutic antibody discovery by overcoming B cell diversity bottlenecks.

Spray-drying converts long-chain RNA into a dry powder composition for pharmaceutical use.

Ultrasensitive procalcitonin assays detect low biomarker concentrations, enabling accurate risk stratification for non-infectious disease progression.

Cyclic boronic acid ester derivatives bind beta-lactamase active sites, restoring beta-lactam antibiotic efficacy against resistant strains.

Bisin lantibiotic inhibits gram-positive and gram-negative microbes while preserving outer membrane integrity.

Oxidized cellulose loaded with minocycline delivers localized antimicrobial activity at low concentrations.

Combining CLEVER-1 inhibition with interleukin blockers activates the immune system to overcome exhaustion.

Semifluorinated alkanes mediate drug penetration through the stratum corneum while maintaining chemical stability.

A biostable intravaginal device uses a drug-containing polymer coating to deliver multipurpose microbicidal and contraceptive agents.

Segmented receptor modulation targets prostaglandin D2 pathways, addressing inadequate treatment of underlying inflammatory processes in asthma.

Lactobacillus johnsonii La1 colonizes the colon to modulate intestinal microflora and stimulate immune responses.

Novel oxazolidinone compounds inhibit Mycobacterium tuberculosis growth through specific structural modifications.

Appending functional peptide domains to the CsgA protein enables amyloid nanofiber networks to display specific activities on biofilm surfaces.

A polymeric wound device delivers gaseous oxygen to maintain antimicrobial silver in an active ionized form.

A mouse artificial chromosome vector maintains exogenous DNA sequences in mammalian cells using a natural centromere and specific chromosomal fragments.

Modifying quinolone cores with heterocyclyl groups overcomes cross-resistance in bacterial strains while maintaining metabolic stability.

Thiazolyl or thiadiazolyl substituted pyridyl compounds selectively inhibit IRAK-4 to treat inflammatory diseases without broad immunosuppression.

Enzymatic cleavage of conjugated nitric oxide donors releases gas locally, minimizing toxicity while dispersing resistant biofilms.

Salt-induced phase inversion creates a porous pullulan-collagen hydrogel that supports viable cell growth and tissue repair.

Specific chemical structures target Mannheimia haemolytica while sparing human health bacteria to resolve antibiotic resistance.